Medicine supervisor bans turnover of some Indian preparations
The State Service of Ukraine for Medicines and Drugs Control has temporarily banned the sale and application of several preparations made by Genom Biotech Pvt. Ltd. (India).
The authority posted its resolution dated November 28 on its official website.
According to the resolution, the authority temporarily bans turnover of six Indian preparations LANZA, COFEX, SIGAN, ENZYMTAL, COLDFLU and TILDA.
In addition, the authority banned Espumisan preparation manufactured by Berlin-Chemie (Menarini Group, Germany) and Ringer's solution.
Advertising
Advertising
MORE ABOUT
Health Ministry continues to prevent private clinics from joining MGP, creates discriminatory conditions – market participants
17:58, 30.01.2025
Dishonest employees of service centers should not question work of those worthy of respect – Interior Minister
16:07, 31.12.2024
Ukrposhta resumes parcel, small package deliveries to Canada
20:28, 24.12.2024
Zelenskyy signs law on enlistment of military personnel in reserve of Border Guard Service
21:39, 17.12.2024
Interfax-Ukraine launches updated access system to its services
21:46, 25.09.2024
LATEST
Ukraine's energy sector losses from Russian strikes surpass $20 bln – Energy Club VP citing RDNA4
20:49, 07.03.2025
EU may grant Ukraine access to single market as part of peace deal
20:12, 07.03.2025
Naftogaz and ORLEN agree on supply of 100 mcm of LNG as part of broad cooperation in this area
15:27, 07.03.2025
Canada opens its market for Ukrainian apples
13:54, 07.03.2025
Ukraine's National Bank raises key policy rate from 14.5% to 15.5%